Ocular Therapeutix, Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC OCUL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,460,457

Value ($000)

17,730

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	17,730	0.0%	1,460,457	12/31/2025
2025 Q3	11/10/2025	13,141	0.0%	1,124,103	9/30/2025
2025 Q2	8/12/2025	10,166	0.0%	1,095,455	6/30/2025
2025 Q1	9/15/2025	8,157	0.0%	1,112,793	3/31/2025
2024 Q4	2/6/2025	9,663	0.0%	1,131,485	12/31/2024
2024 Q3	11/12/2024	9,661	0.0%	1,110,460	9/30/2024
2024 Q2	8/12/2024	3,081	0.0%	450,380	6/30/2024
2024 Q1	5/9/2024	2,849	0.0%	313,036	3/31/2024
2023 Q4	2/6/2024	987	0.0%	221,202	12/31/2023
2023 Q3	11/8/2023	673	0.0%	214,415	9/30/2023
2023 Q2	8/10/2023	1,106	0.0%	214,415	6/30/2023
2023 Q1	5/12/2023	1,087	0.0%	206,249	3/31/2023
2022 Q4	2/13/2023	575	0.0%	204,529	12/31/2022
2022 Q3	11/14/2022	834	0.0%	200,787	9/30/2022
2022 Q2	8/15/2022	806	0.0%	200,369	6/30/2022
2022 Q1	5/13/2022	996	0.0%	201,067	3/31/2022
2021 Q4	2/11/2022	1,346	0.0%	193,093	12/31/2021
2021 Q3	11/16/2021	2,509	0.0%	250,841	9/30/2021
2021 Q2	8/16/2021	3,537	0.0%	249,425	6/30/2021
2021 Q1	5/17/2021	3,977	0.0%	242,297	3/31/2021
2020 Q4	2/16/2021	3,491	0.0%	168,640	12/31/2020
2020 Q3	11/13/2020	1,123	0.0%	147,490	9/30/2020
2020 Q2	8/20/2020	1,104	0.0%	132,447	6/30/2020
2020 Q1	5/15/2020	548	0.0%	110,622	3/31/2020
2019 Q4	2/7/2020	454	0.0%	114,755	12/31/2019